Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of clinical characteristics between patients with ALK-positive and EGFR-positive lung adenocarcinoma.

Respiratory medicine - 1 Feb 2014

Kang Hyo Jae, Lim Hyo-Jeong, Park Jong Sun, Cho Young-Jae, Yoon Ho-Il, Chung Jin-Haeng, Lee Jae Ho, Lee Choon-Taek

Abstract excerpt

BACKGROUND: The discovery of the chromosomal fusion product of anaplastic lymphoma kinase (ALK) with echinoderm microtubule-associated protein-like 4 (EML4) (EML4-ALK) has changed the treatment paradigm of lung cancer. In this study, we analysed the clinical characteristics, including bronchoscopic findings, of patients with EML4-ALK-positive adenocarcinoma and compared them with those of EGFR mutation-positive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anaplastic Lymphoma Kinase

Share to Bronchoscopy

Share to ErbB Receptors

Share to Multivariate Analysis

Share to Neoplasm Staging

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 24361161
DOI: 10.1016/j.rmed.2013.11.020

Genes

ALK
EML4
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of clinical characteristics between patients with ALK-positive and EGFR-positive lung adenocarcinoma.PMID 24361161Read ↗

Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.Semantic proximity Read ↗

Clinicopathological characteristics of patients with non-small-cell lung cancer who harbor EML4-ALK fusion gene: a meta-analysis.Semantic proximity Read ↗

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.Semantic proximity Read ↗

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene.Semantic proximity Read ↗

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.Semantic proximity Read ↗

EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFRSemantic proximity Read ↗

Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lungSemantic proximity Read ↗

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.Semantic proximity Read ↗

A case of lung adenocarcinoma with a concurrent EGFR mutation and ALK rearrangement: A case report and literature review.Semantic proximity Read ↗

Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.Semantic proximity Read ↗

The biology and treatment of EML4-ALK non-small cell lung cancer.Semantic proximity Read ↗

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.